Related Experiment Video
Updated: Jun 29, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Shared Decision-Making in Cardiovascular Risk Factor Management: A Systematic Review and Meta-Analysis
Sabrina Elias1, Yuling Chen1, Xiaoyue Liu2
1Johns Hopkins School of Nursing, Baltimore, Maryland.
Shared decision-making (SDM) interventions showed a slight reduction in decisional conflict and improved HbA1c levels for cardiovascular risk management. More high-quality studies are needed to confirm these findings.
Area of Science:
- Cardiovascular Medicine
- Health Behavior Research
- Health Services Research
Background:
- The role of shared decision-making (SDM) in improving cardiovascular risk management is not fully understood.
- Existing interventions utilizing SDM require further evaluation for their effectiveness.
Approach:
- A systematic review and meta-analysis of randomized clinical trials (RCTs) was conducted.
- Searched multiple databases (Medline, CINAHL, Embase, Cochrane, Web of Science, Scopus, ClinicalTrials.gov) for studies up to June 24, 2022.
- Included 57 RCTs involving 88,578 patients and 1341 clinicians, synthesizing data using a random-effects model.
Key Points:
- SDM interventions were associated with a statistically significant decrease in decisional conflict (Decisional Conflict Scale scores).
- A modest but significant reduction in hemoglobin A1c (HbA1c) levels was observed in patients receiving SDM interventions.
- The quality of the included studies was generally low to fair, with substantial heterogeneity noted in the results.
Conclusions:
- SDM interventions demonstrate a potential to reduce decisional conflict and improve glycemic control (HbA1c) in cardiovascular risk management.
- The current evidence base is limited by study quality and heterogeneity, necessitating high-quality research.
- Further investigation is crucial to establish the definitive impact and optimal implementation of SDM in cardiovascular care.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

